Exemplos de uso de Metsyn em Inglês e suas traduções para o Português
{-}
-
Colloquial
-
Official
-
Medicine
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Official/political
The?CC was similar in women and men with MetSyn p> 0.05.
The prevalence of MetSyn in this sample was 31% 41 MetSyn in 133 participants.
Subclinical CVD has been demonstrated in subjects with MetSyn.
Women with MetSyn tended to have lower?CC -16.8% versus -18.3%, but with no significance p 0.11.
On the other hand,the WC component was present in 45% of the participants without MetSyn.
Men with MetSyn had lower?CC on STE as compared with those without MetSyn -15.5% versus -18.6%, p< 0.01.
Gong et al. have used tissue Doppler to analyze?II in Chinese participants with MetSyn.
On univariate analysis,the presence of MetSyn, weight, WC, LVEF, and LV mass were significantly related to?CC on tagged MRI.
The strain difference between participants with and without MetSyn was small.
We hypothesized that MetSyn is associated with impaired LV circumferential strain?CC, as well as with LV longitudinal strain?LL.
In agreement with other reports,our results support the association between MetSyn and subclinical CVD.
The MLR analysis included presence of MetSyn, LV mass, LVEF, ethnicity, and creatinine, which were significant in the univariate analysis.
Because of the cross-sectional design of our study, a causal relationship between MetSyn and strain cannot be established accurately.
Individuals with MetSyn had lower?LL as compared with those without MetSyn -12.1%± 2.5% versus -13.9%± 2.3, p< 0.01 Table 2.
In another model of MLR analysis, LVEF, LV mass, age, andethnicity were maintained, and the MetSyn variable was replaced for all five components of MetSyn.
In this model, MetSyn was significantly related to?CC even after adjustment for covariates B 2.1%; 95% CI: 0.6-3.5; p< 0.01 Table 3.
We included participants who underwent echocardiography,tagged MRI reference method for?CC, and evaluation for all MetSyn components.
Thus, individuals with MetSyn should be encouraged to improve their quality of life and control all CV risk factors, particularly abdominal obesity.
In another model of MLR analysis, we maintained LVEF, LV mass, ethnicity, and creatinine,and replaced the MetSyn variable for all five components of MetSyn.
As MetSyn is more prevalent in African-Americans and Caucasians than in the Chinese population, a more general conclusion can be drawn from our study.
These results indicate that LV?LL and?CC, markers of subclinical CVD,are impaired in asymptomatic individuals with MetSyn and no history of MI, HF and/or LVEF.
Similarly to STE results, individuals with MetSyn had lower?CC on tagged MRI than those without MetSyn?CC -15.8%± 3.3% versus -17.6%± 2.3%, p< 0.01 Table 2.
Consistent with our findings in African-American and Caucasian participants,they have demonstrated that mean systolic?LL was lower in participants with MetSyn than in controls.
On univariate analysis,?LL was significantly related to MetSyn, weight, BMI, WC, ethnicity, LV mass, LVEF, creatinine, hypertension status, diabetes status, and triglycerides Table 4.
Previous studies using carotid intima-media thickness measured with ultrasound, coronary artery calcium, Tei index, andtissue Doppler have shown the presence of subclinical CV disease CVD in participants with MetSyn.
Again, using all the MetSyn components and all the possible interaction terms between them, only WC maintained significance B 2.0%; 95% CI: 0.7-3.3; p< 0.01.
In addition, models of MLR analysis were created, using the stepwise variable selection procedures,to evaluate the potential association of?CC and?LL on STE and individual MetSyn components, as well as all the possible term interactions between the MetSyn components.
Participants with MetSyn had lower total and LDL-cholesterol than those without MetSyn, probably due to higher usage of lipid-lowering medication.
The WC component was present in 95.1% of the participants with MetSyn, while blood pressure, HDL-cholesterol, FPG, and triglycerides were present in 87.8%, 61.0%, 46.3%, and 43.9%, respectively.
In our data, MetSyn, as defined by NCEP ATP III, was associated with reduced myocardial function as indicated by an impaired?CC and?LL in a sample of MESA participants.